Dissertations / Theses on the topic 'Blood substitutes'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 48 dissertations / theses for your research on the topic 'Blood substitutes.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse dissertations / theses on a wide variety of disciplines and organise your bibliography correctly.
Guerra, Francisco. "Bloody Good: Pros of Synthetic Blood Substitutes." Thesis, The University of Arizona, 2012. http://hdl.handle.net/10150/243889.
Full textGuerra, Andres. "Bad Blood: Cons of Synthetic Blood Substitutes." Thesis, The University of Arizona, 2012. http://hdl.handle.net/10150/243959.
Full textBentley, P. K. "Biocompatibility assessment of novel perfluorochemical emulsions." Thesis, University of Nottingham, 1990. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.293632.
Full textArmstrong, F. H. "Tissue responses to perfluorochemical emulsion components in rats." Thesis, University of Nottingham, 1990. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.276220.
Full textFerreira, Margarida Lourenço. "New Artificial Blood Substitutes using Fluorinated Ionic Liquids." Master's thesis, Universidade Nova de Lisboa, Instituto de Tecnologia Química e Biológica António Xavier, 2016. http://hdl.handle.net/10362/69823.
Full textinfo:eu-repo/semantics/publishedVersion
Alayash, Abdu I. "Hemoglobin-based blood substitutes : redox, signalling and clearance mechanisms." Thesis, University of Essex, 2010. https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.528868.
Full textNing, Jing 1953. "Studies of perfluorochemical surfactant XMO-10 : effect on perfluorochemical blood substitutes." Thesis, McGill University, 1985. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=64471.
Full textMobed, Maryam. "Purification and characterization of carboxymethylchitin-coated liposomes encapsulating hemoglobin as potential blood substitutes." Thesis, McGill University, 1991. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=60008.
Full textThe purified LEHbs display a unimodal size distribution in the submicron range. Analysis of the lipid/Hb content of the liposomes reveals that the variations in the Hb encapsulation efficiency (E$ sb{ rm Hb}$) as a function of the initial Hb concentration (Hb) $ sb{ rm o}$ are insignificant compared to the net augmentation of E$ sb{ rm Hb}$ as a function of the increasing initial lipid concentration. Meanwhile high (Hb) $ sb{ rm o}$s are necessary for the preservation of oxyhemoglobin. A comparative study suggests that FT-IR spectroscopy gives a more accurate quantitative adsorption index while the chitinase-based enzymatic assay should be used as a qualitative detection tool.
Rainbow, Willa Augusta. "Regulation of circulation in the presence of blood substitutes: hormonal and renal influences." DigitalCommons@Robert W. Woodruff Library, Atlanta University Center, 1986. http://digitalcommons.auctr.edu/dissertations/2803.
Full textHernandez, Adrian V., Erin E. Emonds, Brett A. Chen, Alfredo J. Zavala-Loayza, Priyaleela Thota, Vinay Pasupuleti, Yuani M. Roman, Antonio Bernabe-Ortiz, and J. Jaime Miranda. "Effect of low-sodium salt substitutes on blood pressure, detected hypertension, stroke and mortality." BMJ Publishing Group, 2019. http://hdl.handle.net/10757/652462.
Full textWellcome Trust
Revisión por pares
Martinho, Susana Teresa Antunes. "Development of new oxygen therapeutics using fluorinated ionic liquids." Master's thesis, Faculdade de Ciências e Tecnologia, 2012. http://hdl.handle.net/10362/8482.
Full textThe last decade of the 20th century has yielded a remarkable progress in the field of first generation artificial blood substitutes. Emulsions based on perfluorocarbons (PFCs) became one of the main candidates for a safe and reliable artificial blood substitute. The final objective of the present work is to study the fluorinated ionic liquids (FILs) with the purpose of replacing, partially or totally, the PFCs actually used as artificial blood substitutes, thus providing new fluids with tailored advanced properties. With this goal in mind, the thermophysical and thermodynamic characterization of several FILs, was carried out with the aim to select the most appropriate candidate. This characterization involves the measurement and analysis of the decomposition and melting temperature, density, viscosity, refractive index, and ionic conductivity at atmospheric pressure in a temperature range from 298.15 to 353.15 K. Furthermore, the liquid-liquid equilibria of binary mixtures of PFCs and FILs were studied, at atmospheric pressure in a temperature range usually from 293.15 to 343.15 K. The knowledge of the phase behaviour is crucial to the formulation of emulsions used nowadays as suitable oxygen carriers. Finally, Non-Random Two Liquid (NRTL) thermodynamic model was successfully applied to correlate the behaviour of the binary mixtures of PFCs and FILs
Zanusso, Ilenia. "Acellular matrices as tool for renal progenitor differentiation studies and tissue engineering of blood vessels." Doctoral thesis, Università degli studi di Padova, 2013. http://hdl.handle.net/11577/3423024.
Full textLe matrici acellulari rappresentano uno scaffold promettente per l’ingegneria tessutale. Infatti, la matrice extracellulare costituisce un supporto sito-specifico che favorisce la crescita e il differenziamento delle cellule di qualsiasi organo. Ad oggi, le tecniche dell’ingegneria tessutale sono utilizzate sia per lo sviluppo ex vivo di sostituti tessutali, che per studiare la proliferazione e la differenziazione delle cellule quando si trovano all’interno di uno scaffold tridimensionale. In questo lavoro di tesi, i due seguenti progetti sono andati a valutare entrambe le potenzialità di matrici acellulari tessuto-specifiche: 1- valutazione della capacità della matrice acellulare di indurre il differenziamento di progenitori renali da fluido amniotico in cellule renali mature; 2- valutazione della matrice acellulare per la sostituzione di vasi sanguigni. 1- La matrice acellulare renale è stata utilizzata per valutare la capacità differenziativa di progenitori renali da fluido amniotico in modo da valutarne una futura applicazione terapeutica. I progenitori renali sono stati seminati sulla matrice acellulare renale, che, in vitro, ne ha promosso la proliferazione, il mantenimento del fenotipo podocitario e la differenziazione in cellule tubulari. Per valutare in vivo il potenziale differenziativo di queste cellule, la matrice da sola o ripopolata con le cellule è stata impiantata all’interno di un rene di topo nudo. I progenitori renali si sono ulteriormente differenziati, si sono integrati all’interno delle strutture tubulari dell’ospite e hanno promosso la migrazione di cellule differenziate murine all’interno dello scaffold. 2- La matrice acellulare di aorta è stata utilizzata per lo sviluppo di sostituti vasali. Nonostante vasi autologhi o costituiti di polimeri sintetici vengano già utilizzati nella pratica clinica per la ricostruzione di vasi di piccolo diametro (5 mm), numerosi sono gli svantaggi legati al loro utilizzo, quali l’iperplasia della tonaca intima e la degenerazione arteriosclerotica. Lo scopo di questo studio è stato quello di sviluppare sostituti vasali utilizzando come scaffold vasi decellularizzati. Matrici acellulari da sole o ripopolate con cellule endoteliali da microcircolo sono state impiantate nell’aorta di ratto Lewis. Come osservato negli impianti di sola matrice acellulare, la mancanza della copertura endoteliale portava all’iperplasia dell’intima e all’aumento di incidenza dei processi trombotici, sottolineando la necessità di reendotelizzare in vitro il vaso decellularizzato prima dell’impianto in vivo. Infatti, i sostituti vasali costituiti da matrice acellulare e cellule endoteliali da microcircolo hanno dimostrato di avere una buona resistenza al flusso e non presentavano trombi al loro interno. Sebbene questi vasi fossero assottigliati e mostrassero una leggera iperplasia della tonaca intima, questo approccio presentava due principali vantaggi: permetteva di ottenere sostituti vasali in un tempo clinicamente utile ed eliminava la necessità di rimuovere vasi sani per ottenere cellule endoteliali autologhe.
Styslinger, Thomas James. "The Development and Application of Novel Methods for the Chemical Glycosylation of Therapeutic Proteins & A Chemical Approach to Understanding Glycosyltransferases and Their Application in the Synthesis of Complex Carbohydrates." The Ohio State University, 2011. http://rave.ohiolink.edu/etdc/view?acc_num=osu1313009079.
Full textMarques, Elsa Isabel Correia Cabo. "Moléculas simples com aplicação na medicina." Master's thesis, Universidade de Évora, 2009. http://hdl.handle.net/10174/19741.
Full textSathananthan, Saranya. "Modulating fibrin matrix properties via fibrin knob peptide functionalized microgels." Thesis, Georgia Institute of Technology, 2012. http://hdl.handle.net/1853/44905.
Full textShiu, Hoi Ting. "Controlling whole blood activation and resultant clot properties on various material surfaces : a possible therapeutic approach for enhancing bone healing." Thesis, Queensland University of Technology, 2013. https://eprints.qut.edu.au/63628/1/Shiu_Ting_Thesis.pdf.
Full textMacDonald, Shirley Lynn. "Modified haemoglobin as a blood substitute." Thesis, Heriot-Watt University, 1994. http://hdl.handle.net/10399/1360.
Full textBarlag, Rebecca Eileen. "Analytical Measurements in a Blood Substitute." University of Cincinnati / OhioLINK, 2004. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1100013078.
Full textDavies, Anna. "Platelet function in the presence of Synthocytes : a novel platelet substitute." Thesis, University of Nottingham, 2000. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.324048.
Full textPowanda, Doi Douglas. "Polyhemoglobin-superoxide dismutase-catalase blood substitute for ischemia-reperfusion in brain." Thesis, McGill University, 2001. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=33826.
Full textSince our newly developed second-generation hemoglobin-based blood substitute, PolyHb cross-linked with superoxide dismutase and catalase (PolyHb-SOD-CAT), has the ability to scavenge reactive oxygen radicals, we hypothesize that this oxygen-carrying agent is able to deliver the required oxygen to brain tissue and remove the harmful oxygen free radicals in the same instance. In this investigation, we compare the physiological effects of this formulation with that of the first-generation hemoglobin-based blood substitute (PolyHb) on rat brain tissue using a 60-minutes transient global ischemia-reperfusion rat brain model.
Comparative molecular distribution was performed to observe the cross-linking process. Verifications of superoxide dismutase (SOD) and catalase (CAT) activity and oxygen-carrying property of PolyHb-SOD-CAT were also conducted. Tracking of cerebral water contents and colorimetric assay of Evans blue influx into brain tissue were used to evaluate the integrity of the blood-brain-barrier (BBB). This study shows that PolyHb-SOD-CAT can supply oxygen to ischemic tissues without causing reperfusion injury in a global stroke model.
Ottarson, Alan. "The role of nitric oxide scavenging in hemoglobin-based oxygen carrier induced hypertension: systemic and microvascular effects." VCU Scholars Compass, 2014. http://scholarscompass.vcu.edu/etd/3545.
Full textKeipert, Peter E. "Physiological effects of pyridoxylated polyhemoglobin solution as a blood substitute in rats." Thesis, McGill University, 1985. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=73967.
Full textD'Agnillo, Felice. "A novel red blood cell substitute based on crosslinked hemoglobin, superoxide dismutase, and catalase." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1997. http://www.collectionscanada.ca/obj/s4/f2/dsk2/tape16/PQDD_0024/NQ29915.pdf.
Full textWong, Naomi Sie-Wan. "The Development of PolyHb-Fg: a novel blood substitute with the potential to support coagulation." Thesis, McGill University, 2003. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=95667.
Full textLa polyhémoglobine (polyHb) est l'un des substituts du sang les plus prometteurs à l'étude. Ce composé attend l'approbation de la FDA et a déjà été approuvé pour l'usage chirurgical courant en Afrique du Sud. Bien que la polyHb ait connu un succès comme porteur de l'oxygène, nous avons montré dans la présente étude que le manque de plaquettes et des facteurs de coagulation dans les formulations courantes de polyHb, il pourrait y avoir un risque de problèmes de coagulation quand de grands olumes de polyHb sont administrés. Nous développons donc un nouveau substitut du sang qui résoudrait les problèmes potentiels de coagulation dans une situation d'hémodilution, tout en continuant d'assurer le transport de l'oxygène. Nous avons développé le polyhémoglobine-fibrinogène (polyHb-Fg), en réticulant l'hémoglobine et le fibrinogène avec du glutaraldéhyde. Nos essais in vitro ont prouvé que l'agrégation de plaquette n'a pas été augmentée par l'addition du polyHb ou du polyHb-Fg. Lors d'essais in vitro de coagulation de sang entier, l'hémodilution avec le polyHb retarde défavorablement le mécanisme de coagulation. D'autre part une formulation de polyHb-Fg permet d'obtenir un temp de coagulation semblable à celui du sang entier, même en cas d'hémodilution. Ainsi, cette formulation de polyHb-Fg a le potentiel requis pour des applications dans l'injection de grands volumes de produits de remplacement du sang sans interférer avec la coagulation.
Elmer, Jacob James. "Expression, Purification, and Characterization of Mammalian and Earthworm Hemoglobins." The Ohio State University, 2011. http://rave.ohiolink.edu/etdc/view?acc_num=osu1321458620.
Full textHionis, Veronique C. "The Effects of Hemoglobin-Based Oxygen Carriers On Mean Arterial Pressure, Arteriolar Diameter, and Nitric Oxide in the Microcirculation." VCU Scholars Compass, 2006. http://scholarscompass.vcu.edu/etd/1467.
Full textRiha, Johanna. "Feasibility studies to inform a salt substitute intervention to lower blood pressure in rural Ugandan communities." Thesis, University of Cambridge, 2015. https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.709032.
Full textSallach, Rory Elizabeth. "Recombinant elastin-mimetic protein polymers as design elements for an arterial substitute." Diss., Atlanta, Ga. : Georgia Institute of Technology, 2008. http://hdl.handle.net/1853/29614.
Full textCommittee Chair: Elliot Chaikof; Committee Member: Marc Levenston; Committee Member: Robert Nerem; Committee Member: Vincent Conticello; Committee Member: Yadong Wang. Part of the SMARTech Electronic Thesis and Dissertation Collection.
Zhou, Yipin. "Synthesis and Biophysical Characterization of Polymerized Hemoglobin Dispersions of Varying Size and Oxygen Affinity as Potential Oxygen Carriers for use in Transfusion Medicine." The Ohio State University, 2011. http://rave.ohiolink.edu/etdc/view?acc_num=osu1321406529.
Full textBelcher, Donald Andrew. "Oxygenation of Solid Tumor Tissue Facilitated by Polymerized Human Hemoglobins." The Ohio State University, 2019. http://rave.ohiolink.edu/etdc/view?acc_num=osu156294520544597.
Full textMagnan, Laure. "Développement, par ingénierie tissulaire, d’un substitut vasculaire entièrement biologique et humain grâce à l’utilisation d’une approche textile." Thesis, Bordeaux, 2018. http://www.theses.fr/2018BORD0284.
Full textWhen autologous blood vessels are not available for bypass surgery, synthetic grafts are used but display high failure rates. Indeed, despite their good mechanical properties, their synthetic surface lead to thrombosis and intimal hyperplasia, which cause poor long-term patency in many applications. Using tissue engineering, completely biological and human vascular grafts have been produced by rolling sheets of extracellular matrix synthesized by dermal human fibroblasts in vitro. Using a new assembly technique based on a textile approach, grafts were produced three-time faster. To do so, sheets were cut into yarns to construct vascular substitute by weaving. This manuscript includes three articles. The first one aimed at showing the rich composition of the matrix, describing the organization of its complex network of collagens and demonstrating that the devitalization by drying the matrix did not significantly affect this organization. The second one described the mechanical properties of the yarns depending on the twisting, matrix age or different treatments useful for the manufacturing process. It also demonstrated some of the assembly techniques possible with this human yarn, as well as its possible use as a suture or to build a vascular graft. The third article showed the survival of the yarns subcutaneously implanted for 6 month in nude rats. The implants created little inflammatory response, were mildly remodeled and kept a significant mechanical strength. Decellularization did not show results improvement compared to the simple devitalization, demonstrating that the remaining cellular fragments were not a meaningful activator of the innate immune system. To conclude, this thesis is the first demonstration of the production of human textiles, without using any exogenous material and that are mechanically very strong. Both the devitalization and the textile approach have allowed to create a simpler allogeneic model, faster and cheaper but with an intact potential of integration in vivo, that will be studied very soon with a long-term implantation of the textile in the bloodstream
Faivre, Béatrice. "Un transporteur d'oxygène a visée transfusionnelle : l'hémoglobine-dextran 10-benzène-tetracarboxylate évaluation préclinique chez le cobaye." Vandoeuvre-les-Nancy, INPL, 1993. http://www.theses.fr/1993INPL086N.
Full textCunha, Armando dos Santos. "Emprego de veias preservadas em glicerol como substituto de enxerto de nervo: estudo experimental em ratos." Universidade de São Paulo, 2007. http://www.teses.usp.br/teses/disponiveis/5/5158/tde-23012008-170513/.
Full textGreat losses of neural tissue cannot be repaired by primary conventional suturing. In such cases, nerve autografting is considered to be the treatment of choice. In spite of adequate surgical treatment, functional deficits occur. Also, improvement in functional recuperation and decrease in sequelae are expected. There are many techniques aiming at this purpose. The interposition of tubular conduits, as a bridge between the ends of a sectioned nerve, among these the vein graft, is an alternative technique which offers theoretical advantages. The vein is a studied material as possible evaluated tubular conductor experimentally and in clinical cases. Recent studies have given importance in the use of tissues transplants stored in banks. Glycerol is used for tissue preservation, having been told to its use in nerves and vessels. However, it does not have studies of the use of glycerol reserved veins in as substitute of nerve graft. The purpose of this study was to compare, in rats, the neural regeneration degree, using histological analysis and functional analysis, obtained after interposition of a nerve graft, autogenous vein, autogenous vein preserved in glycerol and allograft vein preserved in glycerol. A 5 mm neural gap in the fibular nerve of rats (Lewis breed) has been created under microsurgical techinique. Four groups of six animals each have been divided according to the treatment employed: Group A - control group: replacement of the fibular nerve itself (autograft); Group B - a 1omm segment of external jugular vein was interposed; Group C - a preserved external jugular vein in glycerol 98% per 7 days was interposed in the fibular nerve gap; Group D - external jugular vein preserved in glycerol of Sprague-Dawley rats had been used equal form to group C in Lewis rats. The animals had been sacrificed after 6 weeks for accomplishment of the histological studies. The functional walking track analysis was performed after in the pre-op, and in the pos-op (immediately, 3 and 6 weeks). The control group (autograft) presented similar histological results to the groups of glycerol preserved veins (autogenous vein and allograft vein), however it presented a bigger perineural tecidual reaction and bigger presence of escape axonal if compared with all the groups. The use of autogenous vein without preservation demonstrated histological results with greater neoangiogenesis and presence of connective tissue inside the neo-formed stroma. Histological pattern was similar to other studied groups. The group that used autogenous vein (without glycerol) presented little functional recovery for 3 and 6 weeks. No statistical difference was seen between groups A (autograft) and groups C and C(preserved veins) in the degree of functional recovery.
Malet-Martino, Marie-Catherine. "La resonance magnetique nucleaire du fluor-19 appliquee a l'etude du metabolisme de medicaments fluores." Toulouse 3, 1986. http://www.theses.fr/1986TOU30204.
Full textChang, Wen-Hsiang, and 張文祥. "Polymerized Hemoglobin as Blood Substitutes." Thesis, 2003. http://ndltd.ncl.edu.tw/handle/92600120220449355619.
Full text國立清華大學
化學工程學系
91
ABSTRACT Hemoglobin has been used as raw materials for manufacturing blood substitutes. However, because of its high oxygen affinity and short vascular retention time, limitations on hemoglobin as a blood substitute in clinical therapy have been reported in the literature. To decrease its oxygen affinity, hemoglobin has been modified by pyridoxylation (PLP-Hb) and followed by polymerization with glutaraldehyde. It was reported that the polymerized hemoglobin showed a P50 value of 19 to 22 mm Hg. Nevertheless, the reaction rate of hemoglobin with glutaraldehyde is too fast to control its molecular weight distribution. Additionally, the glutaraldehyde-polymerized hemoglobin is relatively unstable and may release glutaraldehyde residues during storage or sterilization. It was reported that glutaraldehyde is cytotoxic even at low doses. This may impair the biocompatibility of the polymerized products. In an attempt to overcome the aforementioned problems, two naturally occurring crosslinking agents, genipin and reuterin, were used by our group to polymerize hemoglobin. The first study was to investigate the feasibility of using genipin to polymerize hemoglobin as a blood substitute. The results indicated that the rate of hemoglobin polymerization by glutaraldehyde was significantly faster than that by genipin and it readily produced polymers with molecular masses greater than 500,000 daltons. It was found that the maximum degree of hemoglobin polymerization by genipin was approximately 40% if over-polymerization is to be prevented. With increasing the reaction temperature, hemoglobin concentration, and genipin-to-hemoglobin molar ratio, the duration taken to achieve the maximum degree of hemoglobin polymerization by genipin became significantly shorter. The P50 value of the unmodified hemoglobin was 9 mm Hg, while that of the genipin-polymerized PLP-hemoglobin increased to 21 mm Hg. It was found in a rat model that the genipin-polymerized PLP-hemoglobin increased the survive ratio of rats in a 50% blood exchange. The half-life of the unpolymerized hemoglobin in circulation was about 1.5 h, while that of the genipin-polymerized PLP-hemoglobin was approximately 12.5 h. In the second study, we used another naturally occurring crosslinking agent, reuterin, to polymerize hemoglobin. The results indicated that the rate of hemoglobin polymerization by reuterin was significantly slower than that by glutaraldehyde. In an animal study, it was found that animals transfused with the reuterin-polymerized PLP-hemoglobin up to a 50% blood exchange all survived (n = 6), while animals transfused with allograft plasma died in 3~5 h after transfusion (n = 6) and those transfused with phosphate buffered saline (pH 7.4, n = 6) and unpolymerized hemoglobin (n = 6) survived one out of six. The half-life of the unpolymerized hemoglobin in circulation was about 1.5 h, while that of the reuterin-polymerized hemoglobin was approximately 12 h. In conclusion, genipin and reuterin are promising agents to polymerize hemoglobin as blood substitutes.
Page, Thomas Carey. "Oxygen transport by hemoglobin-based blood substitutes." Thesis, 1997. http://hdl.handle.net/1911/19193.
Full textTsai, Lin-Wei, and 蔡令緯. "Hemoglobin Based Artificial Blood Substitutes Using Nanodiamond." Thesis, 2013. http://ndltd.ncl.edu.tw/handle/86031550231972656847.
Full text國立東華大學
物理學系
101
The basics material properties of nanodiamond (ND) are researched for many years. Nowadays, many groups want to apply this material in biomedical application using its advantages such as low cytotoxicity, intrinsic photoluminescence, sharp characteristic Raman signal, only carbon atoms composition and well-developed synthesis technologies. Due to these advantages, nanodiamond could be a potential material on cancer therapy and targeting drug delivery. Studying the ND potential for drug delivery, the first problem we would face is nanodiamonds large aggregation. We can observe it in buffer solution (Phosphate buffered saline, PBS as well as cell growth mediums) or blood plasma. In this work we use blood protein albumin (rat serum albumin, RSA) adsorbed on nanodiamonds surface to prevent the ND aggregation. This effect has been analyzed using UV-visible spectrometer to measure RSA adsorption on nanodiamonds. Particle size and -potential are measured using dynamic light scattering analyzer (DLS analyzer) to evaluate the size of aggregates and the surface charge of cND and cND-RSA complexes. If this method to decrease the aggregation is feasible, in the future it could be used in pre-clinical preparation of ND to prevent the side effects which can arise due to large size aggregation. In bio-medical applications nanodiamonds and their complexes have to be transported by blood circulation to reach the target tissues. If we want to apply any ND complexes in pre-clinical/ clinical studies, the second question we have to face is “does nanodiamonds affect the blood cells, first of all red blood cells (RBC) or not?” In this part of work, we used Raman spectroscopy to measure the oxygenation process of RBC. RBC’s function is to carry or release oxygen, which is bound by protein hemoglobin (Hb) contained in RBC. Hemoglobin conformation depends on oxygenation state and the structure and oxygenation state can be characterized by Raman spectroscopy. We use Raman spectroscopy to estimate the RBC function, using spontaneous oxygenation in the air oxygen-containing atmosphere and purging nitrogen for deoxygenation. Raman spectra were measured every five minutes and the changes of oxygen saturation was calculated using characteristic peaks of oxygenated or deoxygenated state to observe the effects of various treatments on the oxygenation/deoxygenation process. In the third part of work, we try to develop an oxygen carrier based on hemoglobin and cND-RSA, using rat hemoglobin. Using spectroscopic methods we analyzed its adsorption on ND and estimated the oxygenated and deoxygenated states of hemoglobin adsorbed on nanodiamonds surface. We show that 50 nm cND(RSA)-Hb can carry oxygen successfully, however, due to the complicate physiology condition, further use of this kind of oxygen carrier in-vivo needs more preliminary in-vitro investigations.
Arifin, Dian Respati. "Cellular hemoglobin-based oxygen carriers as potential artificial blood substitutes." 2005. http://etd.nd.edu/ETD-db/theses/available/etd-05232005-205232/.
Full textThesis directed by Andre F. Palmer for the Department of Chemical and Biomolecular Engineering. "May 2005." Includes bibliographical references (leaves 146-158).
Kan, Pei, and 甘霈. "Separation and Purification of Hemoglobin as the Raw Material of Blood Substitutes." Thesis, 1996. http://ndltd.ncl.edu.tw/handle/95717985284184810047.
Full textEike, Julie Hughes. "High oxygen affinity polymerized bovine hemoglobin-based oxygen carriers as potential artificial blood substitutes." 2005. http://etd.nd.edu/ETD-db/theses/available/etd-05202005-100650/.
Full textThesis directed by Andre F. Palmer for the Department of Chemical and Biomolecular Engineering. "May 2005." Includes bibliographical references (leaves 122-135).
Lui, Francine Evelyn. "Enhancing the Nitrite Reductase Activity of Modified Hemoglobin: Bis-tetramers and their PEGylated Derivatives." Thesis, 2011. http://hdl.handle.net/1807/31844.
Full textLin, Yen-lin, and 林延霖. "Peptide-polyethyleneglycol Hemoglobin as a Blood Substitute." Thesis, 2003. http://ndltd.ncl.edu.tw/handle/83591441796104123193.
Full text國立中正大學
化學工程研究所
91
Although the current blood supply is much safer due to the improved process of blood screening and testing, people are still concerned about the transmission of HIV or hepatitis virus via blood transfusion. The oxygen-carrying blood substitutes have been intensively studied and hemoglobin-based blood substitutes is most attractive and promising. Hemoglobin solution lacking 2,3-diphosphoglycerate (2,3-DPG) cannot release sufficient oxygen in human body. In this study, therefore, peptides composed of 7~11 amino acids was designed to act like 2,3-DPG, and was crosslinked to the outer structure of hemoglobin through Maleimide — polyethyleneglycol — N-hydroxysuccinimidyl (MAL-PEG-NHS). MAL was the functional group to crosslink with cysteine in the peptide, whereas NHS to crosslink between peptide-PEG and hemoglobin. The results of the oxygen dissociation curve demonstrated that peptide-modified hemoglobin has higher P50 value than unmodified hemoglobin. Hence the peptide-modified hemoglobin can, therefore, become a better product for the red cell substitutes.
Lee, Wen-Long, and 李文龍. "Polymerization of Hemoglobin by Genipin as Blood Substitute." Thesis, 1998. http://ndltd.ncl.edu.tw/handle/81494813122166358762.
Full textTsai, Ching Hsuan, and 蔡靚璇. "Polymerization of Hemoglobin by Genipin for Blood Substitute." Thesis, 1996. http://ndltd.ncl.edu.tw/handle/98281214161793759646.
Full textHu, Meighen, and 胡思元. "Dynamic Measurement System for Oxygen Saturation for Blood Substitute." Thesis, 1999. http://ndltd.ncl.edu.tw/handle/96873164719099836461.
Full text中原大學
醫學工程學系
87
The purpose of this research is to develop a dynamic measurement system for the oxygen saturation in blood substitute. The system is helpful to the development of blood substitute. A sensing probe was designed to carry out the measurement with blood substitute inside a conducting tube. Its working principle is similar to that of a pulse oximeter. Blood pulses were generated by pressing the rubber tube with an electromagnetic device. Light transmission of red and near infrared through the blood sample were measured while changing its oxygen saturation. The dissolved oxygen was monitored by an dissolved oximeter as a reference, and the related oxygen saturation was calculated by using the Hill''s equation. The oxygen saturation calculated from the light transmission was correlated to the value evaluated from the dissolved oximeter.
Chen, Nai-Ming, and 陳乃鳴. "Characterization of Acetyl-Glutathione-Polyethyleneglycol Hemoglobin as a Blood Substitute." Thesis, 2005. http://ndltd.ncl.edu.tw/handle/5bvvts.
Full text國立中正大學
化學工程所
93
Because the public concern for the possible transmission of HIV or hepatitis virus via blood transfusion, the oxygen-carrying blood substitutes have been extensively studied and developed. Among various blood substitutes, hemoglobin-based blood substitutes are most promising. There are two protein structures of hemoglobin, R and T states. Hemoglobin has greater affinity for oxygen in R state than in T state. Inside the red blood cells (RBCs), 2,3-diphosphoglycerate (2,3-DPG) gifted with five negative charges binds to hemoglobin, stabilizing hemoglobin in T state and helping oxygen release from hemoglobin for the rest of tissues. Our goal is to crosslink hemoglobin with the 2,3-DPG-like molecule for better oxygen release. Glutathione (GSH) consisted of three amino acids presents in a substantial amount in cells, serving as an anitoxidant. In physiological condition, the net charge of glutathione is positive one, two negative charges from carboxylic groups and one positive charge from amino group. If we eliminate the positive charge in the amino group by acetylation, we can make acetylated GSH carries two negative charges, which may become a good oxygen modulator for hemoglobin. In this study, acetyl-GSH was crosslinked to the outer structure of hemoglobin through Maleimide— polyethyleneglycol—N-hydroxysuccinimidyl (MAL-PEG-NHS). MAL was the functional group to crosslink PEG with cysteine in GSH, whereas NHS is to crosslink PEG with lysines in hemoglobin. Our results show that the oxygen dissociation curve of hemoglobin crosslinked with acetyl-GSH-PEG shifts to the right as compared to the control. Although the reactivities with nitric oxide are similar between hemoglobin and acetyl-GSH-PEG-hemoglobin, the greater viscosity and particle size of PEG modified hemoglobin will exhibit a better blood vessel response due to the increase of endothelial nitric oxide release and the avoidance of extravascalation of hemoglobin.
Chang, Kun Yu, and 張坤玉. "A Cross-Over Study on the Effects and Mechanisms of Sodium Restricted and Salt Substitute Diets on Blood Pressure." Thesis, 1993. http://ndltd.ncl.edu.tw/handle/20164751411616913460.
Full textYungHsu-Chan and 詹詠絮. "The feasibility of liposomes with cholesterol substituted by phytosterols and the effect of antihypertensive oligopeptides encapsulated in liposomes on blood pressure of spontaneously hypertensive rats." Thesis, 2002. http://ndltd.ncl.edu.tw/handle/09351080049537964457.
Full text輔仁大學
食品營養學系
91
Liposomes that are made up with multilamellar phosphobilayers have cell-membrane-like hollow sphere. Their special characteristics and structure can be used to encapsulate substances to transport and protect materials. The purpose of this study was to use phytosterols, such as β-sitosterol and stigmasterol, as a substitute for cholesterol in liposomes. Their physicochemical properties such as encapsulation efficiency (EE), stabilities of storage, pH, oxidization and pepsin were investigated to assess it possibility. Liposomes prepared with phytosterols or cholesterol exhibited higher encapsulation efficiency of bovine serum albumin (BSA) (EE: 24-36% and 28%, respectively) than those prepared without addition of sterols (EE: 19%). The EE of glucose in liposomes increased with the increasing level of cholesterol or phytosterols added in liposomes, but EE values were not so good as in BSA. In addition, EE of liposomes were increased with repeating dehydration-rehydration cycle in five times. Liposomes at pH 6 or 7 were most stable, irrespective of their sterol compositions. Liposomes storage at 4℃ had a higher residual percentage than those of storage at -20℃ or room temperature. Sterols-containing liposomes were more stable during long-term storage at various temperatures than sterol-free counterparts. Addition of sterols to liposomes was effective in decreasing the TBARS during storage periods, it effects was more markedly when α-tocopherol was added. Fatty acid compositions were comparable after storage, no matter what sterols or α-tocopherol were added or not. Liposomes containing cholesterol or phytosterols were effective in protecting encapsulated oligopeptide from pepsin digestion. Furthermore, Encapsulated oligopeptide in sterols-containing liposomes orally administrated to spontaneously hypertensive rats (SHR) lowered blood pressure slowly but sustainedly, and it blood pressure-lowering effect was similar to that induced by Captopril. The results indicated that replacing cholesterol with phytosterols in preparing liposomes is feasible and recommended.